BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 11351311)

  • 1. Multiple primary cancers of the colon, breast and skin (melanoma) as models for polygenic cancers.
    Dong C; Hemminki K
    Int J Cancer; 2001 Jun; 92(6):883-7. PubMed ID: 11351311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Next Melanoma in Patients With Familial and Sporadic Melanoma by Number of Previous Melanomas.
    Chen T; Fallah M; Försti A; Kharazmi E; Sundquist K; Hemminki K
    JAMA Dermatol; 2015 Jun; 151(6):607-15. PubMed ID: 25671687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple primary (even in situ) melanomas in a patient pose significant risk to family members.
    Chen T; Hemminki K; Kharazmi E; Ji J; Sundquist K; Fallah M
    Eur J Cancer; 2014 Oct; 50(15):2659-67. PubMed ID: 25103454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden.
    Wassberg C; Thörn M; Yuen J; Ringborg U; Hakulinen T
    Br J Cancer; 1996 Jan; 73(2):255-9. PubMed ID: 8546916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of multiple primary cancers following melanoma and non-melanoma skin cancer.
    Stracci F; Fabrizi V; D'Alò D; La Rosa F; Papini M
    J Eur Acad Dermatol Venereol; 2012 Nov; 26(11):1384-8. PubMed ID: 21995613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.
    Tuohimaa P; Pukkala E; Scélo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V; McBride ML; Martos C; Chia KS; Tonita JM; Jonasson JG; Boffetta P; Brennan P
    Eur J Cancer; 2007 Jul; 43(11):1701-12. PubMed ID: 17540555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial risks in in situ cancers from the Family-Cancer Database.
    Hemminki K; Vaittinen P
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):865-8. PubMed ID: 9796630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial and attributable risks in cutaneous melanoma: effects of proband and age.
    Hemminki K; Zhang H; Czene K
    J Invest Dermatol; 2003 Feb; 120(2):217-23. PubMed ID: 12542525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence trends and familial risks in invasive and in situ cutaneous melanoma by sun-exposed body sites.
    Hemminki K; Zhang H; Czene K
    Int J Cancer; 2003 May; 104(6):764-71. PubMed ID: 12640685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden.
    Hemminki K; Li X
    Int J Cancer; 2003 Feb; 103(4):525-30. PubMed ID: 12478670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial risk of cancer shortly after diagnosis of the first familial tumor.
    Bermejo JL; Hemminki K
    J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between ocular melanoma and other primary cancers: an international population-based study.
    Scélo G; Boffetta P; Autier P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Chia KS; Jonasson JG; Martos C; Giblin M; Brennan P
    Int J Cancer; 2007 Jan; 120(1):152-9. PubMed ID: 17036322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial risks for eye melanoma and retinoblastoma: results from the Swedish Family-Cancer Database.
    Hemminki K; Chen B
    Melanoma Res; 2006 Apr; 16(2):191-5. PubMed ID: 16567975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
    Leu M; Reilly M; Czene K
    J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subsequent primary cancers after basal-cell carcinoma: A nationwide study in Finland from 1953 to 1995.
    Milán T; Pukkala E; Verkasalo PK; Kaprio J; Jansén CT; Koskenvuo M; Teppo L
    Int J Cancer; 2000 Jul; 87(2):283-8. PubMed ID: 10861488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of prostate, breast and colorectal cancer after skin cancer diagnosis.
    Levi F; Randimbison L; Te VC; Conconi MM; La Vecchia C
    Int J Cancer; 2008 Dec; 123(12):2899-901. PubMed ID: 18770862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.
    Olsen JH; Möller T; Anderson H; Langmark F; Sankila R; Tryggvadóttír L; Winther JF; Rechnitzer C; Jonmundsson G; Christensen J; Garwicz S
    J Natl Cancer Inst; 2009 Jun; 101(11):806-13. PubMed ID: 19470947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Swedish Family-Cancer Database 2009: prospects for histology-specific and immigrant studies.
    Hemminki K; Ji J; Brandt A; Mousavi SM; Sundquist J
    Int J Cancer; 2010 May; 126(10):2259-67. PubMed ID: 19642094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confirmed cancer trends in families of patients with multiple cancers including cutaneous melanoma.
    Nielsen K; Masback A; Bladstrom A; Lundgren L; Jonsson N; Borg A; Ingvar C; Olsson H
    Br J Dermatol; 2008 Feb; 158(2):429-31. PubMed ID: 18047508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.